The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Renal Function Following Three Distinct Weight Loss Dietary Strategies During 2 Years of a Randomized Controlled Trial
Abstract
OBJECTIVE: This study addressed the long-term effect of various diets, particularly low-carbohydrate high-protein, on renal function on participants with or without type 2 diabetes. RESEARCH DESIGN AND METHODS: In the 2-year Dietary Intervention Randomized Controlled Trial (DIRECT), 318 participants (age, 51 years; 86% men; BMI, 31 kg/m2; mean estimated glomerular filtration rate [eGFR], 70.5 mL/min/1.73 m2; mean urine microalbumin-to-creatinine ratio, 12:12) with serum creatinine <176 μmol/L (eGFR ≥30 mL/min/1.73 m2) were randomized to low-fat, Mediterranean, or low-carbohydrate diets. The 2-year compliance was 85%, and the proportion of protein intake significantly increased to 22% of energy only in the low-carbohydrate diet (P < 0.05 vs. low-fat and Mediterranean). We examined changes in urinary microalbumin and eGFR, estimated by Modification of Diet in Renal Disease and Chronic Kidney Disease Epidemiology Collaboration formulas. RESULTS: Significant (P < 0.05 within groups) improvements in eGFR were achieved in low-carbohydrate (+5.3% [95% CI 2.1–8.5]), Mediterranean (+5.2% [3.0–7.4]), and low-fat diets (+4.0% [0.9–7.1]) with similar magnitude (P > 0.05) across diet groups. The increased eGFR was at least as prominent in participants with (+6.7%) or without (+4.5%) type 2 diabetes or those with lower baseline renal function of eGFR <60 mL/min/1.73 m2 (+7.1%) versus eGFR ≥60 mL/min/1.73 m2 (+3.7%). In a multivariable model adjusted for age, sex, diet group, type 2 diabetes, use of ACE inhibitors, 2-year weight loss, and change in protein intake (confounders and univariate predictors), only a decrease in fasting insulin (β = −0.211; P = 0.004) and systolic blood pressure (β = −0.25; P < 0.001) were independently associated with increased eGFR. The urine microalbumin-to-creatinine ratio improved similarly across the diets, particularly among participants with baseline sex-adjusted microalbuminuria, with a mean change of −24.8 (P < 0.05). CONCLUSIONS: A low-carbohydrate diet is as safe as Mediterranean or low-fat diets in preserving/improving renal function among moderately obese participants with or without type 2 diabetes, with baseline serum creatinine <176 μmol/L. Potential improvement is likely to be mediated by weight loss–induced improvements in insulin sensitivity and blood pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These findings are similar to previous report that evidenced that a low-carbohydrate diet is as safe as Mediterranean or low-fat diets in preserving renal function among moderately obese participants with or without T2DM.26”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
Shai, I., Schwarzfuchs, D., Henkin, Y., Shahar, D. R., Witkow, S., Greenberg, I., Golan, R., Fraser, D., Bolotin, A., Vardi, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708681 · Cited by 2,143
Self-citationReddy, S. T., Wang, C.-Y., Sakhaee, K., Brinkley, L., & Pak, C. Y. C. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.34504 · Cited by 391
Flagged first, then by citations
Research works printed but not linked: 35
- Eckel, 2002, Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease, Circulation, 105, 2923, 10.1161/01.CIR.0000017823.53114.4C · DOI
- Wahba, 2007, Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease, Clin J Am Soc Nephrol, 2, 550, 10.2215/CJN.04071206 · DOI
- Keane, 1999, Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation, Am J Kidney Dis, 33, 1004, 10.1016/S0272-6386(99)70442-7 · DOI
- Asselbergs, 2004, Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria, Circulation, 110, 2809, 10.1161/01.CIR.0000146378.65439.7A · DOI
- Leoncini, 2002, Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach, J Hypertens, 20, 1315, 10.1097/00004872-200207000-00018 · DOI
- Praga, 2006, Obesity, proteinuria and progression of renal failure, Curr Opin Nephrol Hypertens, 15, 481, 10.1097/01.mnh.0000242172.06459.7c · DOI
- Chagnac, 2003, The effects of weight loss on renal function in patients with severe obesity, J Am Soc Nephrol, 14, 1480, 10.1097/01.ASN.0000068462.38661.89 · DOI
- Navaneethan, 2009, Bariatric surgery and progression of chronic kidney disease, Surg Obes Relat Dis, 5, 662, 10.1016/j.soard.2009.01.006 · DOI
- Navaneethan, 2009, Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis, Clin J Am Soc Nephrol, 4, 1565, 10.2215/CJN.02250409 · DOI
- Afshinnia, 2010, Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts, Nephrol Dial Transplant, 25, 1173, 10.1093/ndt/gfp640 · DOI
- Jameel, 1992, Dietary protein intake is not correlated with clinical proteinuria in NIDDM, Diabetes Care, 15, 178, 10.2337/diacare.15.2.178 · DOI
- Friedman, 2012, Comparative effects of low-carbohydrate high-protein versus low-fat diets on the kidney, Clin J Am Soc Nephrol, 7, 1103, 10.2215/CJN.11741111 · DOI · Paper page
- Shai, 2010, Dietary intervention to reverse carotid atherosclerosis, Circulation, 121, 1200, 10.1161/CIRCULATIONAHA.109.879254 · DOI
- National Kidney Foundation, 2002, K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am J Kidney Dis, 39, S1
- Price, 2005, Use of protein:creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review, Clin Chem, 51, 1577, 10.1373/clinchem.2005.049742 · DOI
- Bakker, 1999, Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration, Diabetes Care, 22, 307, 10.2337/diacare.22.2.307 · DOI
- Justesen, 2006, Albumin-to-creatinine ratio in random urine samples might replace 24-h urine collections in screening for micro- and macroalbuminuria in pregnant woman with type 1 diabetes, Diabetes Care, 29, 924, 10.2337/diacare.29.04.06.dc06-1555 · DOI
- Delanaye, 2011, Indexing of renal function parameters by body surface area: intelligence or folly?, Nephron Clin Pract, 119, c289, 10.1159/000330276 · DOI
- Myers, 2006, Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program, Clin Chem, 52, 5, 10.1373/clinchem.2005.0525144 · DOI
- Fouque, 2009, Low protein diets for chronic kidney disease in non diabetic adults, Cochrane Database Syst Rev, CD001892
- Brinkworth, 2010, Renal function following long-term weight loss in individuals with abdominal obesity on a very-low-carbohydrate diet vs high-carbohydrate diet, J Am Diet Assoc, 110, 633, 10.1016/j.jada.2009.12.016 · DOI
- Skov, 1999, Changes in renal function during weight loss induced by high vs low-protein low-fat diets in overweight subjects, Int J Obes Relat Metab Disord, 23, 1170, 10.1038/sj.ijo.0801048 · DOI
- Gross, 2005, Diabetic nephropathy: diagnosis, prevention, and treatment, Diabetes Care, 28, 164, 10.2337/diacare.28.1.164 · DOI · Paper page
- Hansen, 2002, Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy, Kidney Int, 62, 220, 10.1046/j.1523-1755.2002.00421.x · DOI
- Hansen, 1999, Low-protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy, Kidney Int, 55, 621, 10.1046/j.1523-1755.1999.00274.x · DOI
- Pedrini, 1996, The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis, Ann Intern Med, 124, 627, 10.7326/0003-4819-124-7-199604010-00002 · DOI · Paper page
- Velázquez López, 2008, Effect of protein restriction diet on renal function and metabolic control in patients with type 2 diabetes: a randomized clinical trial, Nutr Hosp, 23, 141
- Gross, 2002, Effect of a chicken-based diet on renal function and lipid profile in patients with type 2 diabetes: a randomized crossover trial, Diabetes Care, 25, 645, 10.2337/diacare.25.4.645 · DOI · Paper page
- de Mello, 2006, Withdrawal of red meat from the usual diet reduces albuminuria and improves serum fatty acid profile in type 2 diabetes patients with macroalbuminuria, Am J Clin Nutr, 83, 1032, 10.1093/ajcn/83.5.1032 · DOI
- Möllsten, 2001, Higher intakes of fish protein are related to a lower risk of microalbuminuria in young Swedish type 1 diabetic patients, Diabetes Care, 24, 805, 10.2337/diacare.24.5.805 · DOI
- Ros, 2004, A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial, Circulation, 109, 1609, 10.1161/01.CIR.0000124477.91474.FF · DOI
- Cerasola, 2010, The progressive pathway of microalbuminuria: from early marker of renal damage to strong cardiovascular risk predictor, J Hypertens, 28, 2357, 10.1097/HJH.0b013e32833ec377 · DOI
- Jauregui, 2009, Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria, Curr Opin Nephrol Hypertens, 18, 539, 10.1097/MNH.0b013e32832f7002 · DOI
- de Boer, 2007, Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study, J Am Soc Nephrol, 18, 235, 10.1681/ASN.2006040394 · DOI
- do Carmo, 2009, Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice, Am J Physiol Regul Integr Comp Physiol, 297, R803, 10.1152/ajpregu.00187.2009 · DOI · Paper page
Cited by
Sorted by citations
Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association
Ndumele, C. E., Rangaswami, J., Chow, S. L., Neeland, I. J., Tuttle, K. R., Khan, S. S., Coresh, J., Mathew, R. O., Baker-Smith, C. M., Carnethon, M. R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001184 · Cited by 2,208
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
The Effects of High-Protein Diets on Kidney Health and Longevity
Ko, G.-J., Rhee, C. M., Kalantar-Zadeh, K., & Joshi, S. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020010028 · Cited by 345
Efficacy of Commercial Weight-Loss Programs: An Updated Systematic Review
Gudzune, K. A., Doshi, R. S., Mehta, A. K., Chaudhry, Z. W., Jacobs, D. K., Vakil, R. M., Lee, C. J., Bleich, S. N., & Clark, J. M. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2238 · Cited by 325
Goday, A., Bellido, D., Sajoux, I., Crujeiras, A. B., Burguera, B., García-Luna, P. P., Oleaga, A., Moreno, B., & Casanueva, F. F. (2016) · Nutrition & Diabetes · doi:10.1038/nutd.2016.36 · Cited by 258
Metadata
- Authors
- Tirosh, A., Golan, R., Harman-Boehm, I., Henkin, Y., Schwarzfuchs, D., Rudich, A., Kovsan, J., Fiedler, G. M., Blüher, M., Stumvoll, M., Thiery, J., Stampfer, M. J., & Shai, I.
- Affiliations
- Brigham and Women’s Hospital, Harvard School of Public Health, Boston, Massachusetts, and the Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Tel-Hashomer, Israel
- Ben Gurion University of the Negev, Beer-Sheva, Israel
- Soroka Medical Center, Beer-Sheva, Israel
- Nuclear Research Center Negev, Dimona, Israel
- University Hospital of Bern, Bern, Switzerland
- University of Leipzig, Leipzig, Germany
- Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, and Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston, Massachusetts.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-07-11
- Volume
- 36
- Issue
- 8
- Pages
- 2225-2232
- ISSN
- 0149-5992
- 1935-5548
- PMC
- PMC3714527
- Cited by
- 120
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review